Chandra Bhagat Pharma (BOM:542934) Debt-to-Revenue : 0.18 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Chandra Bhagat Pharma Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Chandra Bhagat Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹223 Mil. Chandra Bhagat Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹4 Mil. Chandra Bhagat Pharma's annualized Revenue for the quarter that ended in Sep. 2024 was ₹1,298 Mil. Chandra Bhagat Pharma's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.17.

Chandra Bhagat Pharma Debt-to-Revenue Historical Data

The historical data trend for Chandra Bhagat Pharma's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chandra Bhagat Pharma Debt-to-Revenue Chart

Chandra Bhagat Pharma Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Revenue

Get a 7-Day Free Trial

0.32

0.38

0.22

0.16

0.07

Chandra Bhagat Pharma Semi-Annual Data
	Mar17	Mar18	Mar19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Debt-to-Revenue	Get a 7-Day Free Trial								0.23	0.13	0.07	0.08	0.18

Competitive Comparison of Chandra Bhagat Pharma's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Chandra Bhagat Pharma's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chandra Bhagat Pharma's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chandra Bhagat Pharma's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Chandra Bhagat Pharma's Debt-to-Revenue falls into.

Save Embed

;

Save Embed

;

Chandra Bhagat Pharma Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Chandra Bhagat Pharma's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(150.135	+	14.133)	/	2213.719
	=	0.07

Chandra Bhagat Pharma's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(222.698	+	4.335)	/	1298.366
	=	0.17

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Sep. 2024) Revenue data.

Chandra Bhagat Pharma Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Chandra Bhagat Pharma's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Chandra Bhagat Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chandra Bhagat Pharma Ltd (BOM:542934) » Definitions » Debt-to-Revenue

Traded in Other Exchanges

N/A

Address

Doctor Ambedkar Road, 323-F Bhagat Bhuvan, Matunga (East), Mumbai, MH, IND, 400019

Website

https://www.cbcpharma.com

Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.

Chandra Bhagat Pharma Headlines

No Headlines